Here at Richmond Pharmacology, we ensure that your clinical regulatory applications meet the requirements for global regulators.

At Richmond Pharmacology, we understand that navigating the complex landscape of regulatory approvals can be daunting. That's why we've assembled a team of experts with extensive knowledge of regulatory requirements across various regions and therapeutic areas. Whether you're a pharmaceutical company looking to bring a new drug to market or a biotech startup seeking regulatory guidance, our team is here to provide tailored solutions to meet your unique needs.

Our experienced Advanced Research Science team will compile all necessary documentation, including writing the information for volunteers, informed consent form and completing the online IRAS application form. Richmond Pharmacology can obtain necessary documentation and specialist opinions for ethics submissions, in order to obtain approvals in a timely manner. We work closely with many ethics committees, local and nationwide, and will select an ethics committee based on study needs.

Our experts will guide you through each step of the regulatory process to ensure a seamless journey. If required, the Principal Investigator will attend the ethics committee meeting to participate in discussions and ensure a smooth approval process.

Contact Richmond Pharmacology today, and let us be your guiding force in achieving regulatory success. Our team of experts is ready to discuss your specific needs, answer your questions, and tailor our services to your unique project requirements.

We ensure your regulatory submissions will fulfil the requirements of the FDA, MHRA, EMA and PMDA.

Get in touch today

Latest news

A first of a kind trial in the fight against malaria

June 12, 2024
Richmond successfully recruits and enrols adults of sub-Saharan ancestry who all complete a first of its kind trial in the treatment of malaria.
Read more

Patient with rare bleeding disorder becomes first to test new treatment

May 22, 2024
The thousands of patients who participate in Richmond’s trials are helping to advance medical science and save lives and, in the process, some make history. In a film released today, one trial participant tells her story.
Read more


AHA Hypertension Scientific Sessions 2024

5 - 8 September 2024
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions
View event